OS RR (95% CI) | P | DFS RR (95% CI) | P | |
---|---|---|---|---|
Age | 0.989 (0.961–1.019) | 0.472 | 1.000 (0.974–1.027) | 0.993 |
Gender | 2.013 (0.278–14.603) | 0.489 | 2.302 (0.318–16.664) | 0.409 |
Smoking | 0.646 (0.345–1.207) | 0.171 | 0.784 (0.425–1.446) | 0.435 |
Alcohol | 0.828 (0.468–1.468) | 0.296 | 0.878 (0.509–1.512) | 0.638 |
Subsite | 1.331 (1.063–1.667) | 0.013 | 1.345 (1.084–1.669) | 0.007 |
T stage | 1.129 (0.674–1.892) | 0.645 | 1.036 (0.632–1.701) | 0.887 |
Lymph node | 1.638 (1.164–2.305) | 0.005 | 1.726 (1.241–2.400) | 0.001 |
Pathological grade | 1.420 (0.769–2.623) | 0.263 | 1.700 (0.933–3.100) | 0.083 |
Postoperation radiotherapy | 1.129 (0.636–2.002) | 0.679 | 1.158 (0.671–1.997) | 0.599 |
Adjuvant chemotherapy | 0.587 (0.283–1.215) | 0.130 | 0.483 (0.248–0.943) | 0.033 |
Multivariable | ||||
Subsite | 1.457 (1.122–1.890) | 0.005 | 1.423 (1.104–1.834) | 0.006 |
Lymph node | 1.628 (1.143–2.317) | 0.007 | 1.725 (1.227–2.424) | 0.002 |
Pathological grade | 1.383 (0.734–2.605) | 0.316 | 1.590 (0.851–2.970) | 0.146 |
Postoperation radiotherapy | 1.184 (0.649–2.162) | 0.582 | 1.169 (0.659–2.073) | 0.594 |
Adjuvant chemotherapy | 0.647 (0.298–1.406) | 0.272 | 0.579 (0.283–1.186) | 0.135 |